View in EDS

1124P Lenvatinib + pembrolizumab (L + P) in participants (Pts) with advanced or recurrent endometrial cancer (aEC): Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.

Saved in:
Bibliographic Details
Title: 1124P Lenvatinib + pembrolizumab (L + P) in participants (Pts) with advanced or recurrent endometrial cancer (aEC): Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.
Authors: Marth, C.1 (AUTHOR), Lorusso, D.2 (AUTHOR), Bidzinski, M.3 (AUTHOR), Salutari, V.4 (AUTHOR), Akıllı, H.5 (AUTHOR), Oaknin, A.6 (AUTHOR), Kaen, D.L.7 (AUTHOR), Nogueira-Rodrigues, A.8 (AUTHOR), Miller, D.S.9 (AUTHOR), Hasegawa, K.10 (AUTHOR), Mackay, H.11 (AUTHOR), Moore, R.G.12 (AUTHOR), Santin, A.D.13 (AUTHOR), Yunokawa, M.14 (AUTHOR), Ye, J.15 (AUTHOR), Slomovitz, B.M.16 (AUTHOR), McKenzie, J.17 (AUTHOR), Meng, R.18 (AUTHOR), Makker, V.19 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS748-S749. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189419566
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1124P Lenvatinib + pembrolizumab (L + P) in participants (Pts) with advanced or recurrent endometrial cancer (aEC): Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Marth%2C+C%2E%22">Marth, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lorusso%2C+D%2E%22">Lorusso, D.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bidzinski%2C+M%2E%22">Bidzinski, M.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Salutari%2C+V%2E%22">Salutari, V.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Akıllı%2C+H%2E%22">Akıllı, H.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oaknin%2C+A%2E%22">Oaknin, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kaen%2C+D%2EL%2E%22">Kaen, D.L.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nogueira-Rodrigues%2C+A%2E%22">Nogueira-Rodrigues, A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miller%2C+D%2ES%2E%22">Miller, D.S.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hasegawa%2C+K%2E%22">Hasegawa, K.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mackay%2C+H%2E%22">Mackay, H.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Moore%2C+R%2EG%2E%22">Moore, R.G.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Santin%2C+A%2ED%2E%22">Santin, A.D.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yunokawa%2C+M%2E%22">Yunokawa, M.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ye%2C+J%2E%22">Ye, J.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Slomovitz%2C+B%2EM%2E%22">Slomovitz, B.M.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McKenzie%2C+J%2E%22">McKenzie, J.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meng%2C+R%2E%22">Meng, R.</searchLink><relatesTo>18</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Makker%2C+V%2E%22">Makker, V.</searchLink><relatesTo>19</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS748-S749. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189419566
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.08.1760
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S748
    Titles:
      – TitleFull: 1124P Lenvatinib + pembrolizumab (L + P) in participants (Pts) with advanced or recurrent endometrial cancer (aEC): Study 309/KEYNOTE-775 and ENGOT-en9/LEAP-001 post-(neo)adjuvant therapy outcomes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Marth, C.
      – PersonEntity:
          Name:
            NameFull: Lorusso, D.
      – PersonEntity:
          Name:
            NameFull: Bidzinski, M.
      – PersonEntity:
          Name:
            NameFull: Salutari, V.
      – PersonEntity:
          Name:
            NameFull: Akıllı, H.
      – PersonEntity:
          Name:
            NameFull: Oaknin, A.
      – PersonEntity:
          Name:
            NameFull: Kaen, D.L.
      – PersonEntity:
          Name:
            NameFull: Nogueira-Rodrigues, A.
      – PersonEntity:
          Name:
            NameFull: Miller, D.S.
      – PersonEntity:
          Name:
            NameFull: Hasegawa, K.
      – PersonEntity:
          Name:
            NameFull: Mackay, H.
      – PersonEntity:
          Name:
            NameFull: Moore, R.G.
      – PersonEntity:
          Name:
            NameFull: Santin, A.D.
      – PersonEntity:
          Name:
            NameFull: Yunokawa, M.
      – PersonEntity:
          Name:
            NameFull: Ye, J.
      – PersonEntity:
          Name:
            NameFull: Slomovitz, B.M.
      – PersonEntity:
          Name:
            NameFull: McKenzie, J.
      – PersonEntity:
          Name:
            NameFull: Meng, R.
      – PersonEntity:
          Name:
            NameFull: Makker, V.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2025 Supplement 2
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 36
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1